These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1913790)

  • 21. Resting echocardiography and quantitative dipyridamole technetium-99m sestamibi tomography in the identification of cardiac allograft vasculopathy and the prediction of long-term prognosis after heart transplantation.
    Ciliberto GR; Ruffini L; Mangiavacchi M; Parolini M; Sara R; Massa D; De Maria R; Gronda E; Vitali E; Parodi O
    Eur Heart J; 2001 Jun; 22(11):964-71. PubMed ID: 11428820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary venous intimal thickening in explanted cardiac allografts. Evidence demonstrating that transplant coronary artery disease is a manifestation of a diffuse allograft vasculopathy.
    Oni AA; Ray J; Hosenpud JD
    Transplantation; 1992 Jun; 53(6):1247-51. PubMed ID: 1604479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic accuracy of coronary angiography and risk factors for post-heart-transplant cardiac allograft vasculopathy.
    Sharples LD; Jackson CH; Parameshwar J; Wallwork J; Large SR
    Transplantation; 2003 Aug; 76(4):679-82. PubMed ID: 12973108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous coronary interventions in cardiac allograft vasculopathy: a single-center experience.
    Colombo P; Bruschi G; Sacco A; Oreglia J; De Marco F; Colombo T; Botta L; Macera F; Turazza F; Frigerio M; Martinelli L; Klugmann S
    Transplant Proc; 2010 May; 42(4):1286-90. PubMed ID: 20534283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unprotected left main coronary artery stenting for cardiac allograft vasculopathy.
    Chan AW; Carere RG; Khatri S; Della Siega A; Ignaszewski AP; Webb JG
    J Heart Lung Transplant; 2001 Jul; 20(7):776-80. PubMed ID: 11448810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraindividual variability of cardiac allograft vasculopathy as assessed by intravascular ultrasound.
    Klauss V; Mudra H; Uberfuhr P; Theisen K
    Am J Cardiol; 1995 Sep; 76(7):463-6. PubMed ID: 7653445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular brachytherapy for treatment of cardiac allograft vasculopathy.
    Klauss V; Stempfle H; Theisen K; Kantlehner R; Poellinger B; Reichart B; Schiele TM
    J Heart Lung Transplant; 2001 Jul; 20(7):792-4. PubMed ID: 11448814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noninvasive detection of coronary allograft vasculopathy by myocardial contrast echocardiography.
    Rodrigues AC; Bacal F; Medeiros CC; Bocchi E; Sbano J; Morhy SS; Mathias W; Andrade JL
    J Am Soc Echocardiogr; 2005 Feb; 18(2):116-21. PubMed ID: 15682047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 'Rapping' up cardiac allograft vasculopathy.
    Khalpey Z; Kushwaha SS
    Clin Cardiol; 2008 Jun; 31(6):286-7. PubMed ID: 17803252
    [No Abstract]   [Full Text] [Related]  

  • 30. The scourge and enigmatic journey of cardiac allograft vasculopathy.
    Mehra MR
    J Heart Lung Transplant; 2017 Dec; 36(12):1291-1293. PubMed ID: 29173389
    [No Abstract]   [Full Text] [Related]  

  • 31. Non-invasive diagnostic of cardiac allograft vasculopathy by 31P magnetic resonance chemical shift imaging.
    Caus T; Kober F; Marin P; Mouly-Bandini A; Quilici J; Métras D; Cozzone PJ; Bernard M
    Eur J Cardiothorac Surg; 2006 Jan; 29(1):45-9. PubMed ID: 16343922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of "angiographically silent" intimal thickening.
    St Goar FG; Pinto FJ; Alderman EL; Valantine HA; Schroeder JS; Gao SZ; Stinson EB; Popp RL
    Circulation; 1992 Mar; 85(3):979-87. PubMed ID: 1537134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravascular ultrasound evidence of angiographically silent allograft vasculopathy inversely correlates with circulating level of hepatocyte growth factor.
    Lee CM; Wu YW; Chou NK; Jui HY; Hsu RB; Wang SS; Chen MF
    J Heart Lung Transplant; 2006 Dec; 25(12):1456-61. PubMed ID: 17178341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT.
    Clemmensen TS; Holm NR; Eiskjær H; Løgstrup BB; Christiansen EH; Dijkstra J; Barkholt TØ; Terkelsen CJ; Maeng M; Poulsen SH
    JACC Cardiovasc Imaging; 2017 Jul; 10(7):773-784. PubMed ID: 28330670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the progression of cardiac allograft vasculopathy by dobutamine stress echocardiography.
    Derumeaux G; Redonnet M; Soyer R; Cribier A; Letac B
    J Heart Lung Transplant; 1998 Mar; 17(3):259-67. PubMed ID: 9563602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac allograft vasculopathy is abrogated by anti-CD8 monoclonal antibody therapy.
    Allan JS; Choo JK; Vesga L; Arn JS; Pins MR; Sachs DH; Madsen JC
    Ann Thorac Surg; 1997 Oct; 64(4):1019-25. PubMed ID: 9354520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic inflammation and metabolic syndrome in cardiac allograft vasculopathy.
    Raichlin ER; McConnell JP; Lerman A; Kremers WK; Edwards BS; Kushwaha SS; Clavell AL; Rodeheffer RJ; Frantz RP
    J Heart Lung Transplant; 2007 Aug; 26(8):826-33. PubMed ID: 17692787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental cardiac allograft vasculopathy in mice.
    Ardehali A; Billingsley A; Laks H; Drinkwater DC; Sorensen TJ; Drake TA
    J Heart Lung Transplant; 1993; 12(5):730-5. PubMed ID: 8241210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Directional coronary atherectomy in heart transplant recipients.
    Jain SP; Ventura HO; Ramee SR; Collins TJ; Isner JM; White CJ
    J Heart Lung Transplant; 1993; 12(5):819-23. PubMed ID: 8241222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac transplant vasculopathy treated by percutaneous coronary intervention.
    Perrotta S; Lentini S; Muré P; Rinaldi M; D'Armini AM; Viganó M
    Minerva Chir; 2008 Oct; 63(5):321-7. PubMed ID: 18923342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.